Lakefront Biotherapeutics American Depositary Shares
LKFT
92 hedge funds and large institutions have $1.09B invested in Lakefront Biotherapeutics American Depositary Shares in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 11 closing their positions.
64% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $1.42M
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
23% more capital invested
Capital invested by funds: $887M → $1.09B (+$201M)
8% more funds holding
Funds holding: 85 → 92 (+7)
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.45% less ownership
Funds ownership: 48.1% → 47.65% (-0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$43.6M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$20.2M |
| 3 |
MAP
Madison Avenue Partners
New York
|
+$10.2M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.15M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.8M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$20M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$8.64M |
| 4 |
Renaissance Technologies
New York
|
-$3.47M |
| 5 |
Primecap Management
Pasadena,
California
|
-$2.97M |
LKFT Hedge Fund Activity: Q3 2025 in Review
92 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2025, worth a combined $1.09B — up 23% from $887M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LKFT positions and 11 closed out — a net gain of 7 holders — while 31 added to existing stakes and 29 trimmed.
The largest buyer was Ameriprise, adding an estimated $43.6M. The largest seller was Fidelity Investments, cutting an estimated $47.8M.
- 92 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2025, up from 85 in Q2 2025.
- Funds reported $1.09B of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2025, up 23% quarter-over-quarter.
- 18 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2025 and 11 closed out, a net change of +7 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2025 was Ameriprise, an estimated $43.6M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2025 was Fidelity Investments, an estimated $47.8M sold.
Based on aggregated 13F filings for Q3 2025.